The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism

Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis

2000 • 2,426 citations

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study

1998 • 2,334 citations

CORONARY-ARTERY CALCIFICATION IN YOUNG ADULTS WITH END-STAGE RENAL DISEASE WHO ARE UNDERGOING DIALYSIS

2000 • 2,241 citations

Principles of Bone Biology

1997 • 1,367 citations

Association of Elevated Serum PO4, Ca × PO4 Product, and Parathyroid Hormone with Cardiac Mortality Risk in Chronic Hemodialysis Patients

2001 • 1,198 citations

The spectrum of bone disease in end-stage renal failure—An evolving disorder

1993 • 737 citations

Calcimimetics with potent and selective activity on the parathyroid calcium receptor

1998 • 616 citations

Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management

2000 • 598 citations

Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure

1999 • 419 citations

19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis.

1998 • 340 citations

Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal Failure

1989 • 324 citations

Pathogenesis of secondary hyperparathyroidism

1999 • 304 citations

The Calcimimetic Agent AMG 073 Lowers Plasma Parathyroid Hormone Levels in Hemodialysis Patients with Secondary Hyperparathyroidism

2002 • 278 citations

Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure

1997 • 250 citations

Are we mismanaging calcium and phosphate metabolism in renal failure?

1997 • 175 citations

Mechanisms through which parathyroid hormone mediates its deleterious effects on organ function in uremia.

1994 • 152 citations

Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation.

1969 • 142 citations

Effects of excess PTH on nonclassical target organs

1997 • 125 citations

Intermittent calcitriol therapy in secondary hyperparathyroidism: A comparison between oral and intraperitoneal administration

1998 • 125 citations

Allosteric activation of the Ca2+ receptor expressed in Xenopus laevis oocytes by NPS 467 or NPS 568.

1998 • 123 citations

Secondary Hyperparathyroidism in Chronic Renal Failure

1969 • 106 citations

Recent developments in the management of secondary hyperparathyroidism

2001 • 97 citations

Expression of extracellular calcium-sensing receptor in human osteoblastic MG-63 cell line

2001 • 93 citations

Hyperphosphatemia in end-stage renal disease patients: Pathophysiological consequences

1999 • 48 citations

Calcium Receptors as Novel Drug Targets

2002 • 46 citations

Who gets renal bone disease before beginning dialysis?

1985 • 45 citations

Hyperparathyroidism and dialysis vintage.

2000 • 42 citations

Secondary hyperparathyroidism in chronic renal failure.

1983 • 42 citations

What is the optimal regimen for vitamin D?

1999 • 19 citations

Deleted Work

1955 • 0 citations